Lantheus Completes Merger with Progenics

June 22, 2020 – Lantheus Holdings, Inc., the parent company of Lantheus Medical Imaging, Inc., announces completion of merger with Progenics Pharmaceuticals, Inc. Learn More

See the Difference

Improved diagnostic information for better patient management

Learn More

Play Video

See the Difference

Brands you know; Quality you trust; Reliability you demand daily

Learn More

See the Difference

Advancing the art of science and imaging

Learn More

News

Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting

Read More

Lantheus Completes Merger with Progenics

Read More

Lantheus Stockholders Approve Share Issuance For Merger with Progenics

Read More

Coronavirus (COVID-19) Updates

Providng you with important information regarding our response to the
C0VID-19 pandemic.
(updated 5/29/2020)

View a recent Lantheus webinar:
COVID-19: Clinical Experiences from the Front Line in NYC

Read More

News

Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting

Read More

Lantheus Completes Merger with Progenics

Read More

Lantheus Stockholders Approve Share Issuance For Merger with Progenics

Read More

callout_technicians

About Us

At Lantheus, we develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care.

Learn More

callout_product

Spotlight

Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.

Learn More

 

callout scientist

Pipeline

We are developing next generation imaging agents to enhance the accuracy, reliability and safety of diagnostic imaging.

Learn More

 

callout_product

Spotlight

Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.

Learn More